 |
Sard Verbinnen & Co. and FTI Consulting are handling 23andMe’s merger with Richard Branson’s VG Acquisition, special purpose acquisition company, in a deal that will take the genetics/research firm public during the second quarter.
23andMe helped pioneer the direct-to-consumer genetic testing market. More than 80 percent of consumers have opted to participate in research to create a database to analyze data and discover new genetic insights.
"As a fellow industry disruptor as well as early investor in 23andMe, we are thrilled to partner with Sir Richard Branson and VG Acquisition Corp. as we approach the next phase of our business, which will create new opportunities to revolutionize personalized healthcare and medicine, " said Anne Wojcicki, CEO and co-founder of 23andMe.
Branson said his team reviewed hundreds of companies for his SPAC, but 23andMe “stands head and shoulders above the rest."
Sard Verbinnen’s Paul Kranhold, John Christiansen and Chris Kittredge represent 23andMe.
FTI Consulting’s Antonia Gray, Grace Altman, Charles Palmer handle VG Acquisition Corp.
Joele Frank handles Crinetics Pharmaceuticals as the specialist for treatments for endocrine diseases agrees to get acquired by Vertex Pharmaceuticals in a deal pegged at $8.8B.
Teneo represents Honeywell spin-off Solstice Advanced Materials as it buys Collected Strategies client Element Solutions in a deal pegged at $14.5B.
Dallas-based Throughline Global Advisors advised Principal Mineral as it acquired Isola Group, maker of copper-clad laminates used in printed circuit boards.
oele Frank works for satellite operator Iridium Communications as it gets acquired by space company Rocket Lab in a deal worth $8B.
Uber’s Mike Lucarelli is moving to NXP Semiconductors as senior VP-investor relations.
